Rise and shine, everyone. Another day is on the way. What will this one hold in store? Certainly, those meetings and deadlines are looming. To prepare, we are quaffing the mandatory cup of stimulation. Feel free to grab a cup yourself. By the way, we are hosing a webinar on Drug Safety on Nov. 16 (see here), so please join us. Meanwhile, here are a few tidbits. Hope your day goes well...
Amlyn Can Withstand Diabetes Setback, CEO Says (Dow Jones)
Big Pharma Avoids Diet Drugs (Dow Jones)
Lilly Loses Bid For Gemzar Patent Rehearing (Indianapolis Business Journal)